Stay updated on Emricasan in NASH Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This update does not alter study details or page functionality.SummaryDifference0.0%

- Check51 days agoChange DetectedFooter update: Revision v3.4.2 added and Revision v3.4.1 removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedThe page shows a minor system revision update (Revision: v3.4.1) with no changes to study content, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check72 days agoChange DetectedUI/text changes include showing/hiding glossary, capitalization tweaks to QC-related labels, and a new Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check80 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4 with no obvious changes to core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.